Literature DB >> 30821001

Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines.

F Rencz1,2, V Brodszky1, L Gulácsi1, M Péntek1, A K Poór3, P Holló3, A Szegedi4,5, É Remenyik4, M Sárdy3, A Langenbruch6, M A Radtke6, M Gutknecht6, M Augustin6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30821001     DOI： 10.1111/jdv.15537

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A.

Authors:  J S Barbieri; J M Gelfand
Journal:  Br J Dermatol       Date:  2019-08-06       Impact factor: 9.302

2.  A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).

Authors:  Fanni Rencz; Ariel Z Mitev; Ákos Szabó; Zsuzsanna Beretzky; Adrienn K Poór; Péter Holló; Norbert Wikonkál; Miklós Sárdy; Sarolta Kárpáti; Andrea Szegedi; Éva Remenyik; Valentin Brodszky
Journal:  Qual Life Res       Date:  2021-03-08       Impact factor: 4.147

3.  Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.

Authors:  John S Barbieri; Zelma C Chiesa Fuxench; Daniel B Shin; Junko Takeshita
Journal:  Qual Life Res       Date:  2021-02-04       Impact factor: 3.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.